Based on trial eligibility, retatrutide is being investigated in adults who broadly meet the following criteria: BMI of 30 kg/m or above (classified as obese), or BMI of 27 kg/m or above with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or dyslipidaemia Adults who have not achieved adequate weight loss through lifestyle interventions alone Retatrutide trials to date have enrolled adults only
Patients can receive the treatments at home for no additional cost and will have the option of chatting with a Rexall pharmacist over the phone to receive personalized education, advice, and ongoing support. Through this collaboration, customers can confidently access Ozempic and Wegovy products from a trusted pharmacy, receive personalized support and guidance from our pharmacists, and manage their care from the comfort of their own home, Rexall COO Jeff Boutilier said in a statement
Recovery from acute kidney injury with diabetic ketoacidosis following SARS-CoV-2 infection: a case report and literature review
A diet rich in anti-inflammatory foods, lean proteins, and complex carbs works synergistically with GLP-1 to help manage PMDD symptoms and support weight loss